End-of-day quote
Korea S.E.
06:00:00 2024-06-11 pm EDT
|
5-day change
|
1st Jan Change
|
284,000
KRW
|
+0.89%
|
|
-2.91%
|
-19.43%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,490,741
|
4,397,245
|
3,373,870
|
3,711,167
|
4,473,421
|
3,569,480
|
-
|
-
|
Enterprise Value (EV)
2 |
4,184
|
5,040
|
3,855
|
4,231
|
4,982
|
3,809
|
3,583
|
3,438
|
P/E ratio
|
65.7
x
|
368
x
|
50.3
x
|
36.5
x
|
30.6
x
|
20.1
x
|
19.4
x
|
16.2
x
|
Yield
|
0.17%
|
0.14%
|
0.18%
|
0.17%
|
0.14%
|
0.17%
|
0.18%
|
0.18%
|
Capitalization / Revenue
|
3.13
x
|
4.09
x
|
2.8
x
|
2.79
x
|
3
x
|
2.18
x
|
2.02
x
|
2.02
x
|
EV / Revenue
|
3.76
x
|
4.68
x
|
3.2
x
|
3.18
x
|
3.34
x
|
2.33
x
|
2.03
x
|
1.95
x
|
EV / EBITDA
|
26.3
x
|
45.7
x
|
18
x
|
16.6
x
|
15.6
x
|
10.7
x
|
9.77
x
|
8.47
x
|
EV / FCF
|
-27.2
x
|
45.9
x
|
21.2
x
|
32.1
x
|
28.8
x
|
19.2
x
|
17.3
x
|
15.9
x
|
FCF Yield
|
-3.67%
|
2.18%
|
4.72%
|
3.12%
|
3.47%
|
5.2%
|
5.78%
|
6.28%
|
Price to Book
|
4.73
x
|
6.02
x
|
4.2
x
|
4.26
x
|
4.59
x
|
3.24
x
|
2.79
x
|
2.45
x
|
Nbr of stocks (in thousands)
|
12,744
|
12,732
|
12,718
|
12,703
|
12,691
|
12,680
|
-
|
-
|
Reference price
3 |
273,920
|
345,361
|
265,283
|
292,157
|
352,500
|
281,500
|
281,500
|
281,500
|
Announcement Date
|
2/7/20
|
2/4/21
|
1/27/22
|
2/8/23
|
2/2/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,114
|
1,076
|
1,206
|
1,332
|
1,491
|
1,635
|
1,767
|
1,763
|
EBITDA
1 |
159.3
|
110.3
|
214.5
|
254.9
|
319.1
|
356.8
|
366.8
|
405.7
|
EBIT
1 |
103.9
|
48.68
|
127.4
|
157
|
220.7
|
263.2
|
274.1
|
316.9
|
Operating Margin
|
9.33%
|
4.52%
|
10.56%
|
11.79%
|
14.8%
|
16.09%
|
15.51%
|
17.97%
|
Earnings before Tax (EBT)
1 |
83.3
|
22.13
|
103.8
|
116.9
|
194
|
244
|
257.2
|
291.6
|
Net income
1 |
52.11
|
11.96
|
81.08
|
76.93
|
159.3
|
178
|
187.5
|
221.9
|
Net margin
|
4.68%
|
1.11%
|
6.72%
|
5.78%
|
10.68%
|
10.88%
|
10.61%
|
12.59%
|
EPS
2 |
4,170
|
939.5
|
5,270
|
7,994
|
11,522
|
14,006
|
14,496
|
17,367
|
Free Cash Flow
3 |
-153,685
|
109,719
|
181,974
|
131,890
|
172,801
|
198,155
|
207,125
|
215,967
|
FCF margin
|
-13,800.71%
|
10,198.36%
|
15,088.37%
|
9,903.76%
|
11,590.5%
|
12,116.8%
|
11,721.24%
|
12,249.62%
|
FCF Conversion (EBITDA)
|
-
|
99,459.77%
|
84,835.58%
|
51,735.49%
|
54,145.08%
|
55,531.74%
|
56,463.62%
|
53,230.15%
|
FCF Conversion (Net income)
|
-
|
917,443.51%
|
224,446.95%
|
171,451.1%
|
108,485.82%
|
111,346.82%
|
110,469.73%
|
97,334.97%
|
Dividend per Share
2 |
461.9
|
471.2
|
480.6
|
490.2
|
500.0
|
488.4
|
494.1
|
503.4
|
Announcement Date
|
2/7/20
|
2/4/21
|
1/27/22
|
2/8/23
|
2/2/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
350.5
|
321.1
|
316.5
|
342.1
|
351.3
|
361.7
|
342.7
|
364.6
|
422.4
|
403.7
|
386.8
|
399.6
|
441
|
422.5
|
401.5
|
EBITDA
1 |
-
|
-
|
54.47
|
72.67
|
64.1
|
84.57
|
57.83
|
-
|
94.72
|
100.9
|
74.1
|
85.6
|
74.3
|
-
|
-
|
EBIT
1 |
42.72
|
38.67
|
29.57
|
46.8
|
37.76
|
60.45
|
33.16
|
57.52
|
70.1
|
76.64
|
50.59
|
58.86
|
68.59
|
70.05
|
52.9
|
Operating Margin
|
12.19%
|
12.04%
|
9.34%
|
13.68%
|
10.75%
|
16.71%
|
9.67%
|
15.78%
|
16.6%
|
18.99%
|
13.08%
|
14.73%
|
15.55%
|
16.58%
|
13.18%
|
Earnings before Tax (EBT)
1 |
34.14
|
35.67
|
26.41
|
37.89
|
16.6
|
55.62
|
25.43
|
56.28
|
56.91
|
74.98
|
51.7
|
48.6
|
59.8
|
72.05
|
54
|
Net income
1 |
17.47
|
19.31
|
18.02
|
25.37
|
13.61
|
43.11
|
16.06
|
54.71
|
47.45
|
55
|
38.2
|
32
|
41.8
|
37.7
|
32.4
|
Net margin
|
4.98%
|
6.01%
|
5.69%
|
7.42%
|
3.87%
|
11.92%
|
4.68%
|
15%
|
11.23%
|
13.63%
|
9.88%
|
8.01%
|
9.48%
|
8.92%
|
8.07%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/27/22
|
4/27/22
|
7/18/22
|
11/1/22
|
2/8/23
|
4/26/23
|
7/28/23
|
11/1/23
|
2/2/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
693
|
643
|
481
|
519
|
508
|
239
|
13.9
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
132
|
Leverage (Debt/EBITDA)
|
4.354
x
|
5.825
x
|
2.244
x
|
2.038
x
|
1.593
x
|
0.6709
x
|
0.0378
x
|
-
|
Free Cash Flow
2 |
-153,685
|
109,719
|
181,974
|
131,890
|
172,801
|
198,155
|
207,125
|
215,967
|
ROE (net income / shareholders' equity)
|
7.93%
|
1.65%
|
9.21%
|
9.89%
|
15.1%
|
17.3%
|
15.4%
|
16.5%
|
ROA (Net income/ Total Assets)
|
3.54%
|
0.63%
|
3.51%
|
4.29%
|
7.65%
|
9.32%
|
8.96%
|
9.67%
|
Assets
1 |
1,471
|
1,898
|
2,310
|
1,794
|
2,082
|
1,909
|
2,092
|
2,294
|
Book Value Per Share
3 |
57,930
|
57,329
|
63,128
|
68,632
|
76,794
|
86,889
|
100,920
|
114,836
|
Cash Flow per Share
3 |
996.0
|
11,901
|
15,876
|
12,773
|
17,062
|
23,752
|
24,556
|
27,291
|
Capex
1 |
166
|
41.8
|
19.9
|
30.4
|
43.7
|
45.8
|
56.9
|
55.8
|
Capex / Sales
|
14.92%
|
3.89%
|
1.65%
|
2.28%
|
2.93%
|
2.8%
|
3.22%
|
3.17%
|
Announcement Date
|
2/7/20
|
2/4/21
|
1/27/22
|
2/8/23
|
2/2/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
281,500
KRW Average target price
410,702
KRW Spread / Average Target +45.90% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.14% | 2.59B | | +19.71% | 43.03B | | +23.86% | 22.7B | | +17.29% | 15.07B | | +23.69% | 14.77B | | +59.32% | 13.05B | | -0.05% | 6.79B | | -14.19% | 6.58B | | -8.87% | 5.73B | | +13.42% | 5.5B |
Generic Pharmaceuticals
|